Sivik Global Healthcare LLC
Registered adviserRegulatory profile
From Form ADV, the SEC filer profile, 13D/13G type codes and N-CEN, never from the name.
| Rosters | Regulatory AUM | Main clients |
|---|---|---|
| Mar 2026 to Oct 2026 | $233,900,360 | Pooled investment vehicles (100%) |
| Mar 2025 to Feb 2026 | $313,714,542 | Pooled investment vehicles (100%) |
| Mar 2024 to Feb 2025 | $276,782,212 | Pooled investment vehicles (100%) |
| May 2023 to Feb 2024 | $253,595,980 | Pooled investment vehicles (100%) |
| Mar 2023 to Apr 2023 | $253,595,980 | Pooled investment vehicles (100%) |
| Apr 2022 to Feb 2023 | $302,034,053 | Pooled investment vehicles (100%) |
Portfolio style
Measured from the filed 13F common-share book for Jun 30, 2026, the newest measured quarter, never from the firm's own description.
Closest benchmark: the Dow Jones Industrial Average as of 2026-07-31, active share 95.6%; sector active share 90.8% against the combined 13F book's sector weights.
Over time 26 measured quarters
How the bands are measured
Style bands measure the filed 13F common-share book each closed quarter, tested in this order. Unknown: under $10,000,000 of valued equity or 5 stocks. Index-like (100+ stocks): active share of 20% or less against the closest benchmark, which is the S&P 500, S&P MidCap 400, S&P SmallCap 600, Russell 1000, Russell 2000, Nasdaq-100 or Dow Jones Industrial Average (weighted by an index-tracking fund's reported holdings or the index's constituents nearest the quarter end, over the names resolved to companies, and only when those are 90%+ of its weight) or every 13F filer's combined book, or index series holding 80%+ of the registered fund assets it advises (N-CEN) and equal to 50%+ of its book. Systematic-like: 500+ stocks, 100%+ annual turnover and a top 10 weight of 25% or less. Concentrated: a top 10 weight of 60%+ or 12 or fewer effective positions. Diversified active: none of these. Turnover is the smaller of buys and sells over average equity value, summed over four quarters: low under 30%, high 100%+. Horizon is the value-weighted number of quarters each position has been held: short under 4, long 12+.
Clone Performance
Build a hypothetical price-return history from this filer's public 13F holdings.
View clone backtestPortfolio Concentration
35 tracked positions · as of Sep 30, 2026 · Δ vs Jun 30, 2026Portfolio Trend
Sector Breakdown
As of Sep 30, 2026| Sector | % Portfolio | Value |
|---|---|---|
| Healthcare | 83.8% | $146,657,772 |
| Unclassified | 16.2% | $28,382,400 |
Last Quarter's Activity
Export CSVAdded To
Positions the filer increased| Ticker | Company | Δ Shares | Shares | Value | Open |
|---|---|---|---|---|---|
| XBI | State Street(R) SPDR(R) S&P(R) Biotech ETF | +30,000 | 180,000 | $28,382,400 | |
| ABT | Abbott Laboratories | +30,000 | 55,000 | $5,435,650 | |
| EHC | Encompass Health Corp | +25,000 | 40,000 | $4,859,600 | |
| EW | Edwards Lifesciences Corp | +25,000 | 45,000 | $3,884,400 | |
| ELV | Elevance Health, Inc. | +9,000 | 14,000 | $5,443,480 | |
| ABBV | AbbVie Inc. | +7,000 | 22,000 | $5,754,980 | |
| UNH | Unitedhealth Group Inc | +5,000 | 15,000 | $5,506,200 | |
| DHR | Danaher Corp | +5,000 | 25,000 | $5,538,750 | |
| JNJ | Johnson & Johnson | +4,000 | 24,000 | $6,353,760 | |
| COR | Cencora, Inc. | +3,000 | 18,000 | $5,404,500 | |
| MCK | Mckesson Corp | +2,500 | 6,500 | $5,549,765 | |
| CAH | Cardinal Health Inc | +1,000 | 25,000 | $5,562,500 | |
| TMO | Thermo Fisher Scientific Inc. | +500 | 8,500 | $5,737,925 | |
| VRTX | Vertex Pharmaceuticals Inc | +500 | 10,500 | $5,489,505 | |
| No positions match the current search. | |||||
Trimmed
Positions the filer reduced| Ticker | Company | Δ Shares | Shares | Value | Open |
|---|---|---|---|---|---|
| WAT | Waters Corp | −5,000 | 10,000 | $4,393,900 | |
| HUM | Humana Inc | −2,300 | 17,700 | $6,753,789 | |
| BIO | Bio-Rad Laboratories, Inc. | −2,000 | 8,000 | $3,021,680 | |
| LLY | ELI LILLY & Co | −770 | 4,230 | $4,894,448 | |
| MTD | Mettler Toledo International Inc | −250 | 2,500 | $3,777,375 | |
| No positions match the current search. | |||||
New Positions
Positions the filer opened this quarter| Ticker | Company | Shares | Value | Open |
|---|---|---|---|---|
| CNC | Centene Corp | 80,000 | $4,969,600 | |
| RVTY | Revvity, Inc. | 30,000 | $4,586,700 | |
| BRKR | Bruker Corp | 65,000 | $4,208,750 | |
| MDT | Medtronic plc | 45,000 | $3,883,050 | |
| RGEN | Repligen Corp | 20,000 | $3,844,600 | |
| CI | Cigna Group | 13,203 | $3,588,971 | |
| AVTR | Avantor, Inc. | 175,000 | $2,633,750 | |
| BNTX | BioNTech SE | 22,000 | $2,162,600 | |
| MRNA | Moderna, Inc. | 10,000 | $1,925,700 | |
| ARGX | Argenx SE | 2,000 | $1,917,820 | |
| MDGL | Madrigal Pharmaceuticals, Inc. | 2,500 | $1,259,900 | |
| TWST | Twist Bioscience Corp | 1,128 | $217,974 | |
| No positions match the current search. | ||||
Sold Out
Positions the filer fully exited| Ticker | Company | Shares | Value | Open |
|---|---|---|---|---|
| AZN | Astrazeneca PLC | 20,000 | $3,792,400 | |
| THC | Tenet Healthcare Corp | 20,000 | $3,741,600 | |
| SYK | Stryker Corp | 10,000 | $3,148,400 | |
| GMED | Globus Medical Inc | 30,000 | $2,370,300 | |
| SNN | Smith & Nephew PLC | 50,000 | $1,440,500 | |
| ISRG | Intuitive Surgical Inc | 9,000 | $4,149 | |
| BSX | Boston Scientific Corp | 62,000 | $3,891 | |
| UHS | Universal Health Services Inc | 17,500 | $3,132 | |
| REGN | Regeneron Pharmaceuticals, Inc. | 4,000 | $3,091 | |
| CVS | CVS HEALTH Corp | 20,000 | $1,436 | |
| No positions match the current search. | ||||
| Ticker | Company | Type | Shares | Value (USD) | % of Portfolio | History |
|---|---|---|---|---|---|---|
| XBI |
State Street(R) SPDR(R) S&P(R) Biotech ETF
|
Added | 180,000 | $28,382,400 | 16.21% | |
| HUM |
Humana Inc
Healthcare
|
Reduced | 17,700 | $6,753,789 | 3.86% | |
| JNJ |
Johnson & Johnson
Healthcare
|
Added | 24,000 | $6,353,760 | 3.63% | |
| MRK |
Merck & Co., Inc.
Healthcare
|
Held | 40,000 | $5,812,400 | 3.32% | |
| ABBV |
AbbVie Inc.
Healthcare
|
Added | 22,000 | $5,754,980 | 3.29% | |
| TMO |
Thermo Fisher Scientific Inc.
Healthcare
|
Added | 8,500 | $5,737,925 | 3.28% | |
| CAH |
Cardinal Health Inc
Healthcare
|
Added | 25,000 | $5,562,500 | 3.18% | |
| MCK |
Mckesson Corp
Healthcare
|
Added | 6,500 | $5,549,765 | 3.17% | |
| DHR |
Danaher Corp
Healthcare
|
Added | 25,000 | $5,538,750 | 3.16% | |
| UNH |
Unitedhealth Group Inc
Healthcare
|
Added | 15,000 | $5,506,200 | 3.15% | |
| VRTX |
Vertex Pharmaceuticals Inc
Healthcare
|
Added | 10,500 | $5,489,505 | 3.14% | |
| ELV |
Elevance Health, Inc.
Healthcare
|
Added | 14,000 | $5,443,480 | 3.11% | |
| ABT |
Abbott Laboratories
Healthcare
|
Added | 55,000 | $5,435,650 | 3.11% | |
| COR |
Cencora, Inc.
Healthcare
|
Added | 18,000 | $5,404,500 | 3.09% | |
| A |
Agilent Technologies, Inc.
Healthcare
|
Held | 30,000 | $5,169,300 | 2.95% | |
| CNC |
Centene Corp
Healthcare
|
NEW | 80,000 | $4,969,600 | 2.84% | |
| LLY |
ELI LILLY & Co
Healthcare
|
Reduced | 4,230 | $4,894,448 | 2.80% | |
| EHC |
Encompass Health Corp
Healthcare
|
Added | 40,000 | $4,859,600 | 2.78% | |
| RVTY |
Revvity, Inc.
Healthcare
|
NEW | 30,000 | $4,586,700 | 2.62% | |
| WAT |
Waters Corp
Healthcare
|
Reduced | 10,000 | $4,393,900 | 2.51% | |
| BRKR |
Bruker Corp
Healthcare
|
NEW | 65,000 | $4,208,750 | 2.40% | |
| EW |
Edwards Lifesciences Corp
Healthcare
|
Added | 45,000 | $3,884,400 | 2.22% | |
| MDT |
Medtronic plc
Healthcare
|
NEW | 45,000 | $3,883,050 | 2.22% | |
| RGEN |
Repligen Corp
Healthcare
|
NEW | 20,000 | $3,844,600 | 2.20% | |
| MTD |
Mettler Toledo International Inc
Healthcare
|
Reduced | 2,500 | $3,777,375 | 2.16% | |
| GILD |
Gilead Sciences, Inc.
Healthcare
|
Held | 25,000 | $3,726,250 | 2.13% | |
| CI |
Cigna Group
Healthcare
|
NEW | 13,203 | $3,588,971 | 2.05% | |
| BIIB |
Biogen Inc.
Healthcare
|
Held | 15,000 | $3,388,200 | 1.94% | |
| BIO |
Bio-Rad Laboratories, Inc.
Healthcare
|
Reduced | 8,000 | $3,021,680 | 1.73% | |
| AVTR |
Avantor, Inc.
Healthcare
|
NEW | 175,000 | $2,633,750 | 1.50% | |
| BNTX |
BioNTech SE
Healthcare
|
NEW | 22,000 | $2,162,600 | 1.24% | |
| MRNA |
Moderna, Inc.
Healthcare
|
NEW | 10,000 | $1,925,700 | 1.10% | |
| ARGX |
Argenx SE
Healthcare
|
NEW | 2,000 | $1,917,820 | 1.10% | |
| MDGL |
Madrigal Pharmaceuticals, Inc.
Healthcare
|
NEW | 2,500 | $1,259,900 | 0.72% | |
| TWST |
Twist Bioscience Corp
Healthcare
|
NEW | 1,128 | $217,974 | 0.12% |
Covers the securities this platform tracks: U.S.-listed common stock and the put/call positions reported on it. A 13F can also report security types outside that coverage — preferred shares, bonds, warrants, untracked share classes — so the filing's own declared total can exceed the figures above. The source filing is linked at the top of this table.